Pembrolizumab/Lenvatinib
Categoría
Drugs Multinational Subsidiaries
Tipo de registro
Biotech Sanitaria
Nombre socio
Producto / Servicio
Pembrolizumab/Lenvatinib
Tipo
Biodrugs/ Drugs
Area terapéutica
Oncología
Propiedades/Indicación
Lenvatinib in combination with Pembrolizumab in Participants with Metastatic Colorectal Cancer who have received and progressed on or after or became intolerant to prior treatment
Fase de desarrollo
P III